Results 81 to 90 of about 19,411 (194)

Evaluation of Serum Vaspin and Chemerin Levels in Type 2 Diabetic and Treated with Anti Diabetic Drugs Metformin and Acarbose in Rats [PDF]

Journal of Advanced Biomedical Sciences, 2015
Background & Objective: The serum levels of adipose tissue hormons, Vaspin and Chemerin, alter in some disorder conditions such as diabetes. The aim of this study is to investigate the effect of two anti-diabetic drugs (Metformin and Acarbose) and their ...
Seyed Mohammad Ali Ghaffari, Mohammad taghi Mansouri, Mohammad Hossein Haghighizadeh, Elham Rafie   +3 more
doaj  

Combining Insulin Glargine with Metformin and Acarbose in Type 2 Diabetes: A Randomized Trial [PDF]

Studies in Multidisciplinary Medical Research
This parallel triple-blind randomized controlled trial evaluated the efficacy of combining insulin glargine with metformin, acarbose, or both in managing blood sugar levels in 87 patients with uncontrolled type 2 diabetes.
Mojgan Sanjari, Malihe Taghizadeh Ghassab, Zohreh Safi, Elnaz Olama, Pegah Arfafathollahkhani, Mehrnaz Soltaninejad, Anahita Behzadi   +6 more
doaj   +1 more source

Exploring the Bioactivity of Acarbose on Autoimmune Diseases

, 2017
乾癬與類風溼性關節炎由Th1與Th17細胞主導，在臨床上為慢性自體免疫疾病。乾癬典型的病徵為皮膚紅腫、鱗片狀表皮增生和異常角質分化；類風濕性關節炎主要特徵包括關節僵硬變形、滑膜炎、軟骨磨損、類風濕性小結及血管有免疫細胞浸潤。Acarbose具有高耐受性，為常見的降血糖藥物。Acarbose為α-glucosidase inhibitors，會干擾小腸刷毛緣α-glucosidases的作用，阻斷澱粉和蔗糖的降解，進而延緩葡萄糖的吸收。近年來研究發現在第二型糖尿病患者身上 ...
趙雅萱, Ya-Hsuan Chao
core  

NMR Data Analysis of Acarbose

Chinese Journal of Magnetic Resonance
Acarbose, an α-glucosidase inhibitor, has been widely used in the treatment of type-II diabetes due to its unique mechanism of action. In this study, comprehensive and accurate 1H and 13C NMR data of acarbose in DMSO-d6, including 1H NMR data of all ...
LI Yujiang, ZHAO Wei, TAO Le, LU Bohua, ZHENG Guo, ZHANG Haiyan, GUO Xiaohe, ZHAO Tianzeng   +7 more
doaj   +1 more source

Role of MalQ Enzyme in a Reconstructed Maltose/Maltodextrin Pathway in Actinoplanes sp. SE50/110

Microorganisms
The pseudotetrasaccharide acarbose, produced by Actinoplanes sp. SE50/110, is a relevant secondary metabolite used in diabetes type II medication.
Camilla März, Sophia Nölting, Lars Wollenschläger, Alfred Pühler, Jörn Kalinowski   +4 more
doaj   +1 more source

(a) The binding mode of acarbose docked with α-glucosidase. (b) Acarbose with the active site MOLCAD surface representation. (c) The binding mode of UA docked with α-glucosidase. (d) UA with the active site MOLCAD surface representation.

, 2015
(a) The binding mode of acarbose docked with α-glucosidase. (b) Acarbose with the active site MOLCAD surface representation. (c) The binding mode of UA docked with α-glucosidase. (d) UA with the active site MOLCAD surface representation.
Kun Zhang (108291), Qingqing Hu (800056), Anming Cheng (800057), Zhengyun Jiang (800058), Dianmeng Li (800055), Panpan Wu (177056), Suqing Zhao (800060), Tianming Huang (800054), Jie Zheng (31208), Luoying Jiao (800059)   +9 more
core   +1 more source

The docked binding mode of acarbose with α-glucosidase.

The docked binding mode of acarbose with α-glucosidase.
Li Kong (286966), Zhenzhen Wang (250368), Yue Zhou (71752), Yuxin Chen (126718), Hongguang Tang (17873758), Jinyang Shen (17734526), Caiping Liu (1691287), Jianhui Zhang (450305), Haiyun Jiang (17873755)   +8 more
core   +1 more source

Cost-effectiveness of acarbose for the management of impaired glucose tolerance in Sweden

, 2005
We assessed the cost-effectiveness of acarbose in the management of patients with impaired glucose tolerance (IGT) in Sweden, based on progression to type 2 diabetes (T2D) and cardiovascular (CV) events reported in the STOP-NIDDM trial population ...
Andersson, Dan,, Chiasson, JL, Quilici, S, Chancellor, J, McGuire, A, Maclaine, G   +5 more
core   +1 more source

Acarbose [PDF]

Reactions Weekly, 2020
  +5 more sources

Metabolic syndrome treatment: focusing on acarbose [PDF]

, 2008
Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients ...
I. E. Chazova, B. B. Mychka
core